COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,432 Articles (22,835 medRxiv, 8,597 bioRxiv)

Most recent first Previous |  Page 874: Articles 8731-8740  | Next

Estimating time-dependent infectious contact: a multi-strain epidemiological model of SARS-CoV-2 on the island of Ireland
Kamiya, T., Alvarez-Iglesias, A., Ferguson, J., Murphy, S., Sofonea, M. T., Fitz-Simon, N.
10.1101/2022.03.25.22272942 — Posted: 2022-03-25
Risk factors and preventive interventions for post Covid-19 condition: systematic reviews
Pillay, J., Rahman, S., Guitard, S., Wingert, A., Hartling, L.
10.1101/2022.03.25.22272949 — Posted: 2022-03-25
Optimized infection control practices augment the robust protective effect of vaccination for ESRD patients during a hemodialysis facility SARS-CoV-2 outbreak
Meller, M. E., Pfaff, B. L., Borgert, A. J., Richmond, C. S., Athas, D. M., Kenny, P. A., Sabin, A. P.
10.1101/2022.03.18.22272356 — Posted: 2022-03-25
Impact assessment of mobility restriction, testing, and vaccination on the COVID-19 pandemic in India
Shin, J., Khuong, Q. L., Abbas, K., Oh, J.
10.1101/2022.03.24.22272864 — Posted: 2022-03-25
THE IMPACT OF ROUTINES ON EMOTIONAL AND BEHAVIOURAL DIFFICULTIES IN CHILDREN AND ON PARENTAL ANXIETY DURING COVID-19
Lees, V., Hay, R., Bould, H., Kwong, A. S. F., Smith, D., Kounali, D., Pearson, R.
10.1101/2022.03.25.22272950 — Posted: 2022-03-25
Vaccine effectiveness with BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine against reported SARS-CoV-2 Delta and Omicron infection among adolescents, Norway, August 2021 to January 2022
Veneti, L., Berild, J. D., Viksmoen Watle, S., Starrfelt, J., Greve-Isdahl, M., Langlete, P., Boas, H., Bragstad, K., Hungnes, O., Meijerink, H.
10.1101/2022.03.24.22272854 — Posted: 2022-03-25
Understanding the role of mask-wearing during COVID-19 on the island of Ireland
Fitz-Simon, N., Ferguson, J., Alvarez, A., Sofonea, M. T., Kamiya, T.
10.1101/2022.03.25.22272946 — Posted: 2022-03-25
Impact of Vaccination, Prior Infection, and Therapy on Delta and Omicron Variants
Wang, X., Zein, J., Ji, X., Lin, D.
10.1101/2022.03.24.22272901 — Posted: 2022-03-25
Vaccine Effectiveness Against Hospitalization Among Adolescent and Pediatric SARS-CoV-2 Cases in Ontario, Canada
Simmons, A. E., Amoako, A., Grima, A., Murison, K., Tuite, A., Fisman, D.
10.1101/2022.03.24.22272919 — Posted: 2022-03-25
Booster dose of BNT162b2 in a CoronaVac primary vaccination protocol improves neutralization of SARS-CoV-2 Omicron variant
Campos, G. R. F., Almeida, N. B. F., Filgueiras, P. S., Corsini, C. A., Gomes, S. V. C., de Miranda, D. A. P., de Assis, J. V., Silva, T. B. S., Alves, P. A., Fernandes, G. R., de Oliveira, J. G., Rahal, P., Grenfell, R. F. Q., Nogueira, M. L.
10.1101/2022.03.24.22272904 — Posted: 2022-03-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).